Chimin(SH:603222) Ge Long Hui A P P·2026-01-23 07:58Core Viewpoint - Jimin Health (603222.SH) expects a significant increase in losses for the fiscal year 2025, projecting a net profit attributable to shareholders of the parent company to be between -210 million to -250 million yuan, compared to a loss of -59.71 million yuan in the same period last year [1] Financial Performance - The company anticipates a net profit attributable to shareholders, excluding non-recurring gains and losses, to be between -205 million to -245 million yuan for 2025 [1] - The projected losses represent a substantial increase compared to the previous year's loss of -59.71 million yuan [1] Factors Influencing Performance - Revenue decline is attributed to factors such as U.S. tariff policies and the "He Qinghong private seal incident," which have further exacerbated the company's financial difficulties [1]